In Compliance

The U.S. Food and Drug Administration (FDA) reports that it is taking action to reduce or eliminate animal testing in the development of certain categories of drugs and other medications.

The U.S. Federal Communications Commission (FCC) has ordered the owners of a Texas ranch to immediately cease operation of a transmitting device that is interfering with licensed public safety communications systems in the area.

The National Association for Amateur Radio (the ARRL) has filed comments with the U.S. Federal Communications Commission (FCC) in response to its request for input on reducing or eliminating unnecessary regulatory requirements.

The U.S. National Institute of Standards and Technology (NIST) has released an updated version of its Privacy Framework in an effort to better align it with its Cybersecurity Guidelines.

U.S. cellular service provider T-Mobile has reportedly received permission from the U.S. Federal Communications Commission (FCC) to conduct experimental testing of equipment using 6G technology.

As the world actively explores the potential benefits of the application and uses of artificial intelligence (AI), the European Union (EU) is taking action to position itself as the leading global AI player.

The U.S. Federal Communications Commission (FCC) has temporarily delayed the implementation of a key aspect of its robocall consent requirements to give affected parties more time to modify their existing communications systems.

Efforts are reportedly underway to preserve some of the defining infrastructure of modern radio technology. The ARRL reports that the National Trust for Canada has launched a “Next Great Save” project to restore some of the original radio towers designed and developed by Guglielmo Marconi, who pioneered the creation of radio wave-based telegraphy in the late 1800s.

Staff at the U.S. Food and Drug Administration (FDA) are reportedly struggling to meet application review deadlines for medical device and tobacco products due to recent staff reductions.

The U.S. Food and Drug Administration (FDA) is also stepping up its efforts to identify FDA-cleared medical devices that have been subsequently modified and that no longer fall within the scope of their original clearance.